NANOPATH INC.
Diagnostics for Women
WEST LEBANON, United States · Founded 2022 · $10.0M raised
- Headquarters
- WEST LEBANON, New Hampshire
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- nanopath.com
- Total Funding
- $10.0M
- Last Round
- $10.0M Series AAug 2022
- Rounds
- 1
About
Nanopath is a women's health diagnostics company developing a first-in-class point-of-care molecular diagnostic platform using nanobiosensing technology. Their platform detects viral, bacterial, and fungal pathogens without nucleic acid amplification, delivering results in under 20 minutes directly in a clinician's office. Founded by Dr. Amogha Tadimety and Dr. Alison Burklund, the company raised $10M in Series A funding co-led by Norwest Venture Partners.
Summary
NANOPATH INC. is a Biotech company based in WEST LEBANON, United States, founded in 2022. It has raised $10.0M in total across 1 round, most recently a $10.0M Series A round in Aug 2022. Investors include Shiv Chaudhary, Medtech Convergence Fund and Alumni Ventures.
Tech & App Stack
1 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Aug 2022
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...